Information Provided By: 
Fly News Breaks for February 12, 2020
ISRG
Feb 12, 2020 | 17:44 EDT
Goldman Sachs analyst Amit Hazan initiated coverage of Intuitive Surgical with a Conviction Buy rating and $725 price target. The analyst believes that the company can generate a "durable" installed base growth with strong U.S. robotic market adoption trends and new geographic drivers that include China. Hazan expects Intuitive Surgical to sustain its high teens procedure growth along with sales and earnings results and also notes "new opportunities" awaiting the company beyond surgery.
News For ISRG From the Last 2 Days
ISRG
Apr 18, 2024 | 17:52 EDT
Check out this evening's top movers from around Wall Street, compiled by The Fly. HIGHER AFTER EARNINGSMetropolitan... To see the rest of the story go to thefly.com. See Story Here
ISRG
Apr 18, 2024 | 17:00 EDT
Sees FY24 gross profit margin 67%-68%. Sees FY24 operating expense up 11%-15%. Sees FY24 capital expenditures 1B-$1.2B. Sees FY24 tax rate 22%-24%. Says five additional procedures will have reimbursement in Japan by June. Says saw particular strength in the U.S. and the U.K. Comments and guidance taken from Q1 earnings conference call.
ISRG
Apr 18, 2024 | 16:08 EDT
ISRG
Apr 18, 2024 | 13:20 EDT
Pre-earnings options volume in Intuitive Surgical is 2.0x normal with calls leading puts 10:9. Implied volatility suggests the market is anticipating a move near 4.9%, or $18.11, after results are released. Median move over the past eight quarters is 5.6%.
ISRG
Apr 18, 2024 | 13:16 EDT
